104 related articles for article (PubMed ID: 35841843)
1. Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool.
Leone JP; Graham N; Tolaney SM; Leone BA; Freedman RA; Hassett MJ; Leone J; Vallejo CT; Winer EP; Lin NU; Tayob N
Eur J Cancer; 2022 Sep; 173():20-29. PubMed ID: 35841843
[TBL] [Abstract][Full Text] [Related]
2. Estimating mortality in women with triple-negative breast cancer: The 'ESTIMATE triple-negative' tool.
Leone JP; Graham N; Leone J; Tolaney SM; Leone BA; Freedman RA; Hassett MJ; Vallejo CT; Winer EP; Lin NU; Tayob N
Eur J Cancer; 2023 Aug; 189():112930. PubMed ID: 37356327
[TBL] [Abstract][Full Text] [Related]
3. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer.
Leone J; Hassett MJ; Freedman RA; Tolaney SM; Graham N; Tayob N; Vallejo CT; Winer EP; Lin NU; Leone JP
JAMA Oncol; 2024 Apr; 10(4):508-515. PubMed ID: 38421673
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with late risks of breast cancer-specific mortality in the SEER registry.
Leone JP; Vallejo CT; Hassett MJ; Leone J; Graham N; Tayob N; Freedman RA; Tolaney SM; Leone BA; Winer EP; Lin NU
Breast Cancer Res Treat; 2021 Aug; 189(1):203-212. PubMed ID: 33893907
[TBL] [Abstract][Full Text] [Related]
5. Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry.
Leone JP; Leone BA; Tayob N; Hassett MJ; Leone J; Freedman RA; Tolaney SM; Winer EP; Vallejo CT; Lin NU
Breast Cancer Res Treat; 2021 Jun; 187(3):843-852. PubMed ID: 33590387
[TBL] [Abstract][Full Text] [Related]
6. Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer after five years from diagnosis: implication for extended endocrine therapy.
Yu KD; Wu J; Shen ZZ; Shao ZM
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2201-9. PubMed ID: 22993034
[TBL] [Abstract][Full Text] [Related]
7. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
8. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
9. Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.
Xu YB; Liu H; Cao QH; Ji JL; Dong RR; Xu D
Cancer Med; 2020 Jun; 9(12):4095-4106. PubMed ID: 32314546
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis.
Zhou P; Zhang WW; Bao Y; Wang J; Lian CL; He ZY; Wu SG
Breast; 2020 Dec; 54():319-327. PubMed ID: 33278648
[TBL] [Abstract][Full Text] [Related]
11. The effect of laterality and primary tumor site on cancer-specific mortality in breast cancer: a SEER population-based study.
Bao J; Yu KD; Jiang YZ; Shao ZM; Di GH
PLoS One; 2014; 9(4):e94815. PubMed ID: 24740002
[TBL] [Abstract][Full Text] [Related]
12. Quantifying the relationship between age at diagnosis and breast cancer-specific mortality.
Johnson HM; Irish W; Muzaffar M; Vohra NA; Wong JH
Breast Cancer Res Treat; 2019 Oct; 177(3):713-722. PubMed ID: 31297648
[TBL] [Abstract][Full Text] [Related]
13. Identify high risk estrogen receptor-positive breast cancer patients for extended endocrine therapy.
Li J; Jiang Y; Liu Y; Shao Z
Breast; 2017 Feb; 31():173-180. PubMed ID: 27866092
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods.
Li J; Liu Y; Jiang Y; Shao Z
PLoS One; 2016; 11(6):e0157322. PubMed ID: 27299729
[TBL] [Abstract][Full Text] [Related]
15. The effect of local therapy on breast cancer-specific mortality of women with occult breast cancer and advanced nodal disease (N2/N3): a population analysis.
Johnson HM; Irish W; Vohra NA; Wong JH
Breast Cancer Res Treat; 2019 Aug; 177(1):155-164. PubMed ID: 31127469
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis.
Cai S; Zuo W; Lu X; Gou Z; Zhou Y; Liu P; Pan Y; Chen S
Front Oncol; 2020; 10():1729. PubMed ID: 33072554
[No Abstract] [Full Text] [Related]
17. Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
Petkov VI; Miller DP; Howlader N; Gliner N; Howe W; Schussler N; Cronin K; Baehner FL; Cress R; Deapen D; Glaser SL; Hernandez BY; Lynch CF; Mueller L; Schwartz AG; Schwartz SM; Stroup A; Sweeney C; Tucker TC; Ward KC; Wiggins C; Wu XC; Penberthy L; Shak S
NPJ Breast Cancer; 2016; 2():16017. PubMed ID: 28721379
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
Hu G; Hu G; Zhang C; Lin X; Shan M; Yu Y; Lu Y; Niu R; Ye H; Wang C; Xu C
BMC Cancer; 2020 Feb; 20(1):136. PubMed ID: 32085753
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer-Specific Mortality in Small-Sized Tumor with Stage IV Breast Cancer: A Population-Based Study.
Zheng YZ; Wang XM; Fan L; Shao ZM
Oncologist; 2021 Feb; 26(2):e241-e250. PubMed ID: 33075188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
